The Crimson Bench

Company ModelIntegrated Company Model

Biotech / R&D-Stage — End-to-End Operating Model

Program burn → milestone inflow → runway → cash at data.

$250

Business Drivers

Programs

Pipeline burn.

Milestone

A capital inflow event.

Horizon

How long to model.

Capital & Value

Cash and implied value.

The Integrated Picture

Monthly burn

$750,000

Runway (pre-milestone)

40 mo

Cash at horizon

$13,000,000

Cash at milestone

$26,500,000

Runs out?

No

Implied value at data

$200,000,000

Cash Runway

MonthMonthly BurnInflowCash
Month 1$750,000$29,250,000
Month 3$750,000$27,750,000
Month 6$750,000$25,500,000
Month 9$750,000$23,250,000
Month 12$750,000$21,000,000
Month 15$750,000$18,750,000
Month 18$750,000$10,000,000$26,500,000
Month 21$750,000$24,250,000
Month 24$750,000$22,000,000
Month 27$750,000$19,750,000
Month 30$750,000$17,500,000
Month 33$750,000$15,250,000
Month 36$750,000$13,000,000

Burn Economics

MetricValue
Active programs3
Burn / program / month$200,000
G&A / month$150,000
Total monthly burn$750,000
Milestone payment$10,000,000

The Operator's Read

At $750,000/mo burn, the $30,000,000 plus the $10,000,000 milestone carries the pipeline through the horizon with $13,000,000 to spare. Reaching the readout funded supports the $200,000,000 implied value. A bespoke model adds probability-weighted milestones and dilution.

Interactive preview · Educational model, not financial advice · Built by The Crimson Bench

About This Model

A full operating model of a pre-revenue biotech. Each program burns cash monthly; overhead sits on top; a milestone payment injects capital mid-plan; and the model tracks runway to the value-inflection readout. Cash, not revenue, is the whole game here.

The Linked Driver Groups

Everything is connected — here is what feeds the model.

Programs

Pipeline burn.

Active programs · Burn / program / month · G&A / month

Milestone

A capital inflow event.

Milestone month · Milestone payment

Horizon

How long to model.

Months to simulate

Capital & Value

Cash and implied value.

Starting cash · Implied value at data

Assumptions & Limitations

  • The model is deterministic and monthly — it projects your drivers forward with clear arithmetic, one scenario at a time.
  • Defaults are illustrative benchmarks. The paid version ships in Excel so you can wire in your real chart of accounts.
  • For a model built entirely around your business — hiring waves, fundraising rounds, working capital — commission a bespoke engagement.
  • Educational decision-support tool — not financial, investment, tax, or legal advice.

Frequently Asked Questions

What is the Biotech / R&D-Stage — End-to-End Operating Model?

A full operating model of a pre-revenue biotech. Each program burns cash monthly; overhead sits on top; a milestone payment injects capital mid-plan; and the model tracks runway to the value-inflection readout. Cash, not revenue, is the whole game here.

What makes it "end-to-end"?

Unlike a single calculator, this model links 4 driver groups — Programs, Milestone, Horizon, Capital & Value — into one integrated picture. Change any driver and revenue, margin, cash, runway, and valuation all move together.

What do I get for $250?

The full interactive model plus an editable Excel version, a documented methodology, and board-ready base/bull/bear scenarios. Want it wired to your real numbers and chart of accounts? That's a bespoke engagement — see the Enterprise page.

Is this financial advice?

No. It's an educational decision-support model built to your assumptions — not financial, investment, tax, or legal advice.

Other Company Models

The Crimson Bench · Est. 2002 · Founded in New York City

Want this model built around your real numbers?

Verified corporate accounts only. Ivy League-educated. Flat-rate pricing. 14-day no-cause cancellation.

25,000+ Ivy League Executives · 150,000+ Global Consultants · 48-Hour Deployment